Trade Trends of glaxosmithkline research & development ltd

from Jan 2022 to Sept 2025
Shipments Imported: 0
As Buyer Trade Value (USD): $0
Shipments Exported: 232
As Supplier Trade Value (USD): $1.75 M

Import and Export shipments of "glaxosmithkline research & development ltd"

As Supplier
Shipper NameHS CodeShipment Date
300214Jan 9, 2026
glaxosmithkline research & development ltd
300214Jan 9, 2026
glaxosmithkline research & development ltd
300214Jan 9, 2026
glaxosmithkline research & development ltd
300214Jan 9, 2026
glaxosmithkline research & development ltd
300214Jan 9, 2026
Premium Content Locked

Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.

Trading Partners of glaxosmithkline research & development ltd

Top Companies "glaxosmithkline research & development ltd" is exporting to (by Value USD)

Buyer202420232022
worldwide commercial ventures ltd
1.5 M--
glaxosmithkline colombia sa
-250.45 K-
lock_icon
--2.01 K
lock_icon
912.78--
lock_icon
545.99137.55-

Markets in which glaxosmithkline research & development ltd trades

Top Countries "glaxosmithkline research & development ltd" is exporting to (by Value USD)

Importing Country202420232022
country flagsnigeria
1.5 M--
country flagscolombia
-250.45 K-
country flagsrussia
--2.01 K
country flagscosta rica
912.78--
country flagsuzbekistan
545.99137.55-

Products/HS Codes traded by glaxosmithkline research & development ltd

Top HS Codes Exported by "glaxosmithkline research & development ltd"

USD 1.03 M | 4.31%

Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives

USD 467.43 K | 4.31%

Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other

USD 240.01 K | 2.16%

Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale

USD 881.57 | 1.29%

Organic chemicals Heterocyclic compounds with nitrogen hetero-atom(s) only. -- Other

USD 9.88 K | 0.86%

Pharmaceutical products Pharmaceutical goods specified in Note 4 to this Chapter. -- Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses

Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Subscribe to Intel Now→

Similar Companies to glaxosmithkline research & development ltd

Companies exporting similar HS Codes as of "glaxosmithkline research & development ltd" in united kingdom

Other Buyers and Suppliers in united kingdom who deal in similar products like glaxosmithkline research & development ltd